Access reports, video coverage and attendee insights from our US Pharma and Biotech series.

Reports

Pharma Dealmaking in a Disrupted World

Discover where big pharma is placing its best and why, how licensing deals and evolving in value and structure. Uncover analysis on what to expect in the next wave of biopharma consolidtation and get ahead of the summit.

• Where big pharma is placing its bets, and why
• How licensing deals are evolving in value and structure
• The commercial implications of China’s growing role in innovation
• What to expect in the next wave of biopharma consolidation

Bringing AI into Biopharma

AI is revolutionizing the biopharma industry—but how far has it come, and what challenges remain? Our newly launched report, explores the impact of AI from drug discovery to supply chain automation, offering insights into the future of the industry.

Obesity Drugs

Download the free industry report by FT Live. 'Obesity Drugs: Market Dynamics and Growth Potential'Explore our industry report addressing the worldwide obesity epdidemic and the explosion in demand fueling innovation and investment.

Sessions On Demand

View Sessions On-Demand

Explore sessions from two of our events in the pharma series:
US Pharma and Biotech Summit 2025
What does Trump 2.0 mean for pharma?
Building the next generation of biotech companies
Global Pharma and Biotech Summit 2025
Pharma in China - delivering or decoupling?
AI in pharma - From trial and error to business as usual

2025 Attendee List: 
See who registered to attend in 2025

Complete the form to download the complete 2025 attendee list, showcasing senior executives, board-level leaders, government representatives, institutional investors, entrepreneurs and subject-matter experts from leading organisations worldwide.

2025 Event Brochure:
Learn more about the event

Ahead of the 2026 Event Brochure launching, download last years brochure to explore a snapshot of the agenda, full list of speakers and networking opportunities.

Secure your pass

Gain access to in-person sessions and networking drinks. Network and connect with your peers.

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice